ExploreWatchlistsPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Total liabilities

SATO PHARMACEUTICAL CO.,LTD. (E00954)

Market cap
P/E ratio
Sato Pharmaceutical develops and sells over-the-counter medicines, prescription drugs, and health products to consumers and medical institutions globally.
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Jul 31, 202321,634+9.38%
Jul 31, 202219,779+6.45%
Jul 31, 202118,580-5.84%
Jul 31, 202019,733-9.94%
Jul 31, 201921,910+10.92%
Jul 31, 201819,753+7.96%
Jul 31, 201718,297-2.42%
Jul 31, 201618,751+3.61%
Jul 31, 201518,098+8.08%
Jul 31, 201416,745

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat